Laura Marie Newinski - 07 Aug 2026 Form 4 Insider Report for Brookfield Private Equity Fund LP

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 07 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Aug 2026, 11:46:43 UTC
Prior SEC filing: 08 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Craig Ruckman, Attorney-in-Fact, Attorney-in-Fact

Key filing fact

Laura Marie Newinski filed Form 4 for Brookfield Private Equity Fund LP on 07 Aug 2026.

Key facts

This page summarizes Laura Marie Newinski's Form 4 filing for Brookfield Private Equity Fund LP.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Aug 2026, 11:46.

Change

Previous filing in this sequence was filed on 08 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002088410 Primary reporting owner

Newinski Laura Marie

Relationship: Director
Address: C/O BAM PIC (PRIVATE EQUITY), 250 VESEY STREET, NEW YORK
Signature: /s/ Craig Ruckman, Attorney-in-Fact, Attorney-in-Fact
Signature date: 07 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker transaction

Class B-2 Limited Partnership Units

Award

Transaction value
Shares: +1,358
Change %: +47%
Price: $0.000000^*
Shares after: 4,251
Date: 07 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Class B-2 limited partnership units were granted to the reporting person in accordance with the independent director compensation program established by the Registrant's general partner.